Sana Biotechnology Inc (SANA) Stock Price, Quote & News

Company Profile

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including type 1 diabetes, B cell mediated autoimmune diseases, and oncology. The company's product pipeline includes UP421, a HIP-modified allogeneic primary islet cell product, which is in phase 1 clinical trial to treat type 1 diabetes; SC451, a HIP-modifi...

Industry: Biotechnology

Sector: Healthcare

Phone: 206 701 7914

Website: www.sana.com

Address:

188 East Blaine Street, Suite 400, Seattle, United States

BBraggHillBoys May. 15 at 8:06 PM

$SANA Bullish absorption

0 · Reply

mastergambler May. 15 at 6:24 PM

$SANA

0 · Reply

Eskayes May. 15 at 5:36 PM

$SANA this insider Bishop has some track record. God bless. He owns 2% of outstanding. Nice bet!

0 · Reply

FullTrust May. 15 at 5:23 PM

$SANA and it was $69 milly offering Fook it

0 · Reply

BriOnH May. 15 at 4:56 PM

$SANA "brings the total capital raised since the end of the first quarter of 2026 to approximately $94 million and extends the company’s expected cash runway to mid-2027." We should know by the end of this cash runway if sc451 works like we think it will. Make or break data moment here, but first things first and lets get that friggen IND. https://sana.gcs-web.com/news-releases/news-release-details/sana-biotechnology-announces-sale-approximately-69-million

1 · Reply

StockMomentumLab May. 15 at 3:40 PM

BIOTECH OPEN TAPE (5/15): mixed red/green across the sector as catalysts drive early volatility and rotation.-3 👉Click to view @StockMomentumLab for timely updates amid the volatility. $TARA -3% 12-mo TARA-002 data $SANA -4% $69M share sale $PVLA -5% Ph2 TOIVA data $INMB -6% MINDFuL read $AARD -24% HERO/OLE unblinded data shock High volatility, data-driven moves dominating biotech flow out of the gate.

0 · Reply

Harold2029 May. 15 at 1:22 PM

$SANA This will be HUGE! … esp with A.I. resources coming on line to shorten the time line for sucesss. 100x is plausible.

0 · Reply

OpenOutcrier May. 15 at 1:02 PM

$SANA (-5.4% pre) Sana Biotechnology raises $69 million through share sale https://ooc.bz/l/102538

0 · Reply

SKIJK May. 15 at 1:11 AM

$SANA MAYO Clinic buying 15 million shares. I believe at $3.30, Time to BUY!

0 · Reply

mastergambler May. 14 at 7:08 PM

$SANA dilution, dilution, and dilution...

2 · Reply

Sana Biotechnology Announces Sale of Approximately $69 Million of Shares Through its At-the-Market (ATM) Facility

2026-05-12T22:28:22.000Z - 3 days ago

Sana Biotechnology presents preclinical data for in vivo CAR T cell therapy

May 12, 2026, 5:20 PM EDT - 3 days ago

Sana Biotechnology Transcript: Bank of America Global Healthcare Conference 2026

May 12, 2026, 4:05 PM EDT - 3 days ago

Sana Biotechnology Presents Preclinical Data for In Vivo CAR T Cell Therapy SG293 Surrogate Demonstrating Cell-Specific Delivery, Potent CAR T Cell Generation, and Deep B Cell Depletion in NHPs

2026-05-11T20:42:28.000Z - 4 days ago

Sana Biotechnology reports Q1 non-GAAP EPS (14c), consensus (15c)

May 11, 2026, 4:05 PM EDT - 4 days ago

Sana Biotechnology Reports First Quarter 2026 Financial Results and Business Updates

2026-05-11T17:02:47.000Z - 5 days ago

Sana Biotechnology initiated with a Buy at Rodman & Renshaw

2026-05-08T18:45:07.000Z - 8 days ago

Sana Biotechnology options imply 5.3% move in share price post-earnings

May 5, 2026, 4:05 PM EDT - 10 days ago

Sana Biotechnology to Present at the BofA Securities 2026 Healthcare Conference

Apr 27, 2026, 4:30 PM EDT - 18 days ago

Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting

2026-04-14T13:23:10.000Z - 4 weeks ago

Sana Biotechnology price target raised to $7 from $6 at Wedbush

2026-04-13T20:18:08.000Z - 4 weeks ago

Sana Biotechnology announces SC451 strategic collaboration with Mayo Clinic

2026-03-13T13:10:51.000Z - 2 months ago

Sana announces follow-up results from first-in-human study transplanting UP421

Mar 11, 2026, 1:40 PM EDT - 2 months ago

Sana Biotechnology Transcript: The Citizens Life Sciences Conference 2026

2026-03-03T22:25:38.000Z - 2 months ago

Sana Biotechnology files automatic mixed securities shelf

2026-03-03T21:25:24.000Z - 2 months ago

Sana Biotechnology reports Q4 EPS (16c), consensus (13c)

Mar 3, 2026, 4:05 PM EST - 2 months ago

Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates

Mar 2, 2026, 1:10 PM EST - 2 months ago

Sana Biotechnology Transcript: TD Cowen 46th Annual Health Care Conference

Feb 23, 2026, 4:05 PM EST - 2 months ago

Sana Biotechnology to Present at March 2026 Investor Conferences

2026-02-17T14:16:15.000Z - 3 months ago

Sana Biotechnology appoints Piper as EVP, CFO

Jan 14, 2026, 12:45 PM EST - 4 months ago

Sana Biotechnology Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 7, 2026, 4:26 PM EST - 4 months ago

Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference

2026-01-06T15:25:24.000Z - 4 months ago

Sana Biotechnology price target raised to $7 from $6 at BofA

2025-12-08T14:05:59.000Z - 5 months ago

Sana Biotechnology announces publication of in vivo gene editing

Dec 8, 2025, 9:00 AM EST - 5 months ago

Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform

Dec 3, 2025, 2:35 PM EST - 5 months ago

Sana Biotechnology Transcript: Evercore ISI 8th Annual HealthCONx Conference

Dec 2, 2025, 2:30 PM EST - 5 months ago

Sana Biotechnology Transcript: Citi Annual Global Healthcare Conference 2025

Nov 24, 2025, 4:05 PM EST - 6 months ago

Sana Biotechnology to Present at December 2025 Investor Conferences

Nov 12, 2025, 1:30 PM EST - 6 months ago

Sana Biotechnology Transcript: TD Cowen Immunology and Inflammation Summit

2025-11-06T23:25:54.000Z - 6 months ago

Sana Biotechnology reports Q3 EPS (16c), consensus (19c)

2025-11-06T20:25:18.000Z - 6 months ago

Sana Biotechnology options imply 17.5% move in share price post-earnings

2025-10-30T10:25:41.000Z - 7 months ago

Sana Biotechnology price target raised to $8 from $5 at Citizens JMP

2025-10-15T17:45:20.000Z - 7 months ago

Sana Biotechnology strength attributed to EMJ Capital long call

2025-09-24T11:45:09.000Z - 8 months ago

Wedbush bullish on Sana Biotechnology, initiates with an Outperform

2025-09-24T10:50:09.000Z - 8 months ago

Sana Biotechnology initiated with an Outperform at Wedbush

Sep 9, 2025, 9:30 AM EDT - 8 months ago

Sana Biotechnology Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 8, 2025, 11:30 AM EDT - 8 months ago

Sana Biotechnology Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 4, 2025, 8:00 AM EDT - 9 months ago

Sana Biotechnology Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Sep 2, 2025, 3:15 PM EDT - 9 months ago

Sana Biotechnology Transcript: Citi's Biopharma Back to School Conference

Aug 28, 2025, 8:00 AM EDT - 9 months ago

IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies

FHTX IQV MRNA

Aug 26, 2025, 4:05 PM EDT - 9 months ago

Sana Biotechnology to Present at September 2025 Investor Conferences

Aug 20, 2025, 4:05 PM EDT - 9 months ago

Sana Biotechnology Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares

2025-08-11T20:55:26.000Z - 9 months ago

Sana Biotechnology reports Q2 EPS (16c), consensus (21c)

2025-08-08T17:05:14.000Z - 10 months ago

Sana Biotechnology options imply 10.8% move in share price post-earnings

Aug 6, 2025, 11:24 PM EDT - 10 months ago

Sana Biotechnology Announces Pricing of Public Offering

Aug 6, 2025, 4:38 PM EDT - 10 months ago

Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Aug 6, 2025, 7:00 AM EDT - 10 months ago

Seres Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates

MCRB

Aug 4, 2025, 11:35 AM EDT - 10 months ago

Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 Diabetes

Jun 23, 2025, 10:05 AM EDT - 11 months ago

Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression

Jun 10, 2025, 8:40 AM EDT - 1 year ago

Sana Biotechnology Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

Jun 9, 2025, 4:05 PM EDT - 1 year ago

Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions

Jun 4, 2025, 2:35 PM EDT - 1 year ago

Sana Biotechnology Transcript: Jefferies Global Healthcare Conference 2025

May 28, 2025, 4:05 PM EDT - 1 year ago

Sana Biotechnology to Present at June 2025 Investor Conferences

May 13, 2025, 12:20 PM EDT - 1 year ago

Sana Biotechnology Transcript: BofA Securities 2025 Healthcare Conference

May 12, 2025, 4:05 PM EDT - 1 year ago

Sana Biotechnology to Present at the BofA Securities 2025 Healthcare Conference

Mar 17, 2025, 4:05 PM EDT - 1 year ago

Sana Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates

Mar 3, 2025, 3:10 PM EST - 1 year ago

Sana Biotechnology Transcript: TD Cowen 45th Annual Healthcare Conference

Feb 24, 2025, 4:05 PM EST - 1 year ago

Sana Biotechnology to Present at the Cowen 45th Annual Health Care Conference

Jan 15, 2025, 12:00 PM EST - 1 year ago

Sana Biotechnology Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 8, 2025, 4:05 PM EST - 1 year ago

Sana Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 8, 2025, 7:25 AM EST - 1 year ago

This Biotech Stock Just Soared 240%. Why It Can Go Higher.

BBraggHillBoys May. 15 at 8:06 PM

$SANA Bullish absorption

0 · Reply

mastergambler May. 15 at 6:24 PM

$SANA

0 · Reply

Eskayes May. 15 at 5:36 PM

$SANA this insider Bishop has some track record. God bless. He owns 2% of outstanding. Nice bet!

0 · Reply

FullTrust May. 15 at 5:23 PM

$SANA and it was $69 milly offering Fook it

0 · Reply

BriOnH May. 15 at 4:56 PM

1 · Reply

StockMomentumLab May. 15 at 3:40 PM

0 · Reply

Harold2029 May. 15 at 1:22 PM

$SANA This will be HUGE! … esp with A.I. resources coming on line to shorten the time line for sucesss. 100x is plausible.

0 · Reply

OpenOutcrier May. 15 at 1:02 PM

$SANA (-5.4% pre) Sana Biotechnology raises $69 million through share sale https://ooc.bz/l/102538

0 · Reply

SKIJK May. 15 at 1:11 AM

$SANA MAYO Clinic buying 15 million shares. I believe at $3.30, Time to BUY!

0 · Reply

mastergambler May. 14 at 7:08 PM

$SANA dilution, dilution, and dilution...

2 · Reply

BBraggHillBoys May. 14 at 7:06 PM

$SANA is this a scam as some suggest here or: hypoimmune engineering, stem cell derived therapies, delivery systems, and regenerative medicine all in one platform thesis?

0 · Reply

brut_2_3 May. 14 at 6:53 PM

$SANA Anyone have any thoughts on the high volume today? It seems like almost 10x more than normal.

0 · Reply

BBraggHillBoys May. 14 at 6:46 PM

$SANA punishing the uncertainty that still lingers

0 · Reply

red1 May. 14 at 6:33 PM

$SANA anyone know why the volume is so high with real price movement?

2 · Reply

Harold2029 May. 14 at 6:28 PM

$SANA This should STILL be at least $30 …. The prospects of a remedy for Diabetes and its at: $3.10? You’ve GOT TO BE KIDDING ME!

0 · Reply

brut_2_3 May. 14 at 6:22 PM

$SANA Added some more today. Total holding now at 85k shares. Pretty much all my money is in this play. Been waiting patiently for years — hopefully one day it all pays off and the fruits come through.

1 · Reply

Harold2029 May. 14 at 5:41 PM

$SANA …. MAYO Clinic buying 15 million shares. Some analyst is predicting a 100x. Find a remedy for diabetes and you get the 100x. Im in! GLTA.

0 · Reply

FullTrust May. 14 at 2:01 PM

$SANA 20 mil vol hit tape at open So diluting or monster in the making

4 · Reply

FullTrust May. 14 at 1:34 PM

$SANA

0 · Reply

LoveRetailFroth May. 14 at 12:48 PM

$RXRX Good Morning ☕️ AI in healthcare is THE use case for AI. This & $TEM 💎 & $SANA $AMLX $SMMT

0 · Reply

mastergambler May. 14 at 11:47 AM

$SANA and the stock manipulation even more massive. Hopefully the scam is not massive too.

2 · Reply

BBraggHillBoys May. 14 at 12:10 AM

$SANA if successful, the upside is massive, but the scientific and operational complexity of this company is also massive.

0 · Reply

Market Cap	873.84M
Revenue (ttm)	0.00
Net Income (ttm)	-244.17M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	3,701,700
Avg Vol	3,669,600
Day's Range	N/A - N/A
Shares Out	278.29M
Stochastic %K	14%
Beta	2.17
Analysts	Strong Sell
Price Target	$9.50